Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Acquisitions & Divestments (2017 - 2019)

Historic Change in Acquisitions & Divestments for Cogent Biosciences (COGT) over the last 3 years, with Q2 2019 value amounting to $8.0 million.

  • Cogent Biosciences' Change in Acquisitions & Divestments rose 1934.33% to $8.0 million in Q2 2019 from the same period last year, while for Dec 2019 it was $23.0 million, marking a year-over-year decrease of 3902.39%. This contributed to the annual value of $294.5 million for FY2024, which is 1602.88% up from last year.
  • As of Q2 2019, Cogent Biosciences' Change in Acquisitions & Divestments stood at $8.0 million, which was up 1934.33% from $15.0 million recorded in Q1 2019.
  • Cogent Biosciences' Change in Acquisitions & Divestments' 5-year high stood at $15.0 million during Q4 2018, with a 5-year trough of $4.0 million in Q1 2017.
  • Its 3-year average for Change in Acquisitions & Divestments is $8.2 million, with a median of $6.4 million in 2017.
  • Data for Cogent Biosciences' Change in Acquisitions & Divestments shows a peak YoY increase of 20000.0% (in 2018) and a maximum YoY decrease of 1166.67% (in 2018) over the last 5 years.
  • Cogent Biosciences' Change in Acquisitions & Divestments (Quarter) stood at $5.0 million in 2017, then surged by 200.0% to $15.0 million in 2018, then plummeted by 46.69% to $8.0 million in 2019.
  • Its Change in Acquisitions & Divestments was $8.0 million in Q2 2019, compared to $15.0 million in Q1 2019 and $15.0 million in Q4 2018.